Success with lifestyle monotherapy in youth with new-onset type 2 diabetes

23Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BACKGROUND: Evidence is lacking to support the efficacy of lifestyle modification as first-line therapy in the clinical management of type 2 diabetes mellitus (T2DM) in adolescents. METHODS: A retrospective chart review of youth diagnosed with T2DM between 1999 and 2008 was conducted. The authors describe the percentage of youth presenting with glycosylated hemoglobin (HbA 1c) of <9% who achieved/maintained target glycemic control (HbA1c ≤7.0%) with lifestyle monotherapy during the year following diagnosis. RESULTS: Among the 275 youth with T2DM, 38% (n=104) presented with an HbA1c <9% and were prescribed lifestyle monotherapy at diagnosis. Of the 80 youth who had sufficient follow-up data over 12 months, 54% successfully maintained target glycemic control solely with lifestyle management. The mean HbA1c score at diagnosis was lower in youth who where successful on lifestlye monotherapy compared with those who were not successful. CONCLUSIONS: A significant proportion of youth newly diagnosed with T2DM presenting with an HbA1c <9% effectively achieved/ maintained target glycemic control with lifestyle recommendations alone for 12 months. ©2012 Pulsus Group Inc. All rights reserved.

Cite

CITATION STYLE

APA

Wittmeier, K. D. M., Wicklow, B. A., Sellers, E. A. C., Griffith, A. T. R., Dean, H. J., & McGavock, J. M. (2012). Success with lifestyle monotherapy in youth with new-onset type 2 diabetes. Paediatrics and Child Health, 17(3), 129–132. https://doi.org/10.1093/pch/17.3.129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free